Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Revolution Medicines, Inc. - Common Stock (NQ:RVMD)

151.56 -2.17 (-1.41%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 22, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,935,097
Open	154.42
Bid (Size)	151.01 (200)
Ask (Size)	151.92 (500)
Prev. Close	153.73
Today's Range	151.44 - 156.25
52wk Range	34.00 - 156.25
Shares Outstanding	106,313,250
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Biotech Fund Sells $44.5 Million Erasca Stake After Massive 700% Rally ↗

May 18, 2026

This clinical-stage biotech develops targeted therapies for RAS/MAPK pathway cancers, advancing a pipeline of novel oncology candidates.

Via The Motley Fool

Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase ↗

May 17, 2026

Corvus Pharmaceuticals develops immuno-oncology therapies, advancing clinical candidates for cancer and immune-related conditions.

Via The Motley Fool

Performance

YTD	+91.8%	+91.8%
1 Month	+12.0%	+12.0%
3 Month	+46.2%	+46.2%
6 Month	+105.8%	+105.8%
1 Year	+309.9%	+309.9%

More News

Why One Healthcare Fund Increased Its Kodiak Sciences Stake Amid an Eye-Popping Rally ↗

May 17, 2026

Via The Motley Fool

Revolution Medicines Inc (NASDAQ:RVMD) Q1 2026 Loss Widens Amid Clinical Promise ↗

May 06, 2026

Via Chartmill

Vir Biotechnology Stock Has Doubled This Past Year. One Fund Just Bought 1.2 Million Shares ↗

May 17, 2026

Via The Motley Fool

This Nuclear Tech Stock Grew Revenue 27%, But a Fund Still Slashed Its Stake ↗

May 15, 2026

Via The Motley Fool

This Retail Stock Is Down 10% in a Year Despite Record Revenue. A Fund Just Cut Its Stake ↗

May 15, 2026

Via The Motley Fool

This Trade School Stock Is Up 135%. Here’s Why a Fund Still Bought 459,000 Shares ↗

May 15, 2026

Via The Motley Fool

Callaway Stock Has Soared 150%. Here’s Why One Fund Still Bought 1.1 Million Shares ↗

May 15, 2026

Via The Motley Fool

Revolution (RVMD) Q1 2026 Earnings Transcript ↗

May 06, 2026

Via The Motley Fool

Revolution Medicines Has a Market Cap of $29 Billion and Generates No Revenue. Here's Why Its Valuation May Not Be as Ridiculous as It Seems ↗

April 27, 2026

Via The Motley Fool

Revolution Medicines (RVMD): The New Titan of the RAS Pathway (2026 Research Feature)

April 15, 2026

Via Finterra

The RAS Revolution: A Deep Dive into Revolution Medicines’ Path to Dominance (2026 Report)

April 14, 2026

Via Finterra

Which stocks are moving on Monday? ↗

April 13, 2026

Via Chartmill

What's going on in today's session ↗

April 13, 2026

Via Chartmill

These stocks are gapping in today's session ↗

April 13, 2026

Via Chartmill

Which stocks are moving before the opening bell on Monday? ↗

April 13, 2026

Via Chartmill

Daraxonrasib Demonstrates Unprecedented Overall Survival Benefit in Pivotal Phase 3 RASolute 302 Clinical Trial in Patients with Metastatic Pancreatic Cancer

April 13, 2026

From Revolution Medicines, Inc.

Via GlobeNewswire

Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential? ↗

March 22, 2026

Via The Motley Fool

This Biotech Stock Winner Is Up 72%, but a $4 Million Trim Signals a Slight Reset ↗

March 21, 2026

Via The Motley Fool

This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth ↗

March 21, 2026

Via The Motley Fool

This $8.9 Million Buy Targets a Stock Down 68% With $322 Million in Cash ↗

March 21, 2026

Via The Motley Fool

DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing ↗

March 21, 2026

Via The Motley Fool

This $91 Million Position Signals Conviction in a Biotech Stock Eyeing FDA Decision This Year ↗

March 20, 2026

Via The Motley Fool

Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet. ↗

March 19, 2026

Via The Motley Fool

Frequently Asked Questions

Is Revolution Medicines, Inc. - Common Stock publicly traded?

Yes, Revolution Medicines, Inc. - Common Stock is publicly traded.

What exchange does Revolution Medicines, Inc. - Common Stock trade on?

Revolution Medicines, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Revolution Medicines, Inc. - Common Stock?

The ticker symbol for Revolution Medicines, Inc. - Common Stock is RVMD on the Nasdaq Stock Market

What is the current price of Revolution Medicines, Inc. - Common Stock?

The current price of Revolution Medicines, Inc. - Common Stock is 151.56

When was Revolution Medicines, Inc. - Common Stock last traded?

The last trade of Revolution Medicines, Inc. - Common Stock was at 05/22/26 04:00 PM ET

What is the market capitalization of Revolution Medicines, Inc. - Common Stock?

The market capitalization of Revolution Medicines, Inc. - Common Stock is 16.11B

How many shares of Revolution Medicines, Inc. - Common Stock are outstanding?

Revolution Medicines, Inc. - Common Stock has 16B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.